GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 723 filers reported holding GLAXOSMITHKLINE PLC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $202,000 | -24.6% | 4,667 | -29.1% | 0.09% | -25.6% |
| Q1 2016 | $268,000 | +4.3% | 6,580 | +3.1% | 0.12% | +8.7% |
| Q4 2015 | $257,000 | +4.9% | 6,380 | 0.0% | 0.12% | +6.5% |
| Q3 2015 | $245,000 | +11.4% | 6,380 | +33.8% | 0.11% | -10.7% |
| Q1 2015 | $220,000 | +7.8% | 4,770 | 0.0% | 0.12% | +34.4% |
| Q4 2014 | $204,000 | -6.8% | 4,770 | 0.0% | 0.09% | -2.2% |
| Q3 2014 | $219,000 | -14.1% | 4,770 | 0.0% | 0.09% | -16.4% |
| Q2 2014 | $255,000 | 0.0% | 4,770 | 0.0% | 0.11% | -6.0% |
| Q1 2014 | $255,000 | -76.0% | 4,770 | -76.0% | 0.12% | -78.5% |
| Q4 2013 | $1,061,000 | +74.5% | 19,865 | +63.8% | 0.54% | +85.7% |
| Q3 2013 | $608,000 | -1.3% | 12,125 | -1.6% | 0.29% | -1.0% |
| Q2 2013 | $616,000 | – | 12,325 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |